Investors / United States / TransPacific Venture Capital Partners
TransPacific Venture Capital Partners
Venture capital · San Francisco, CA, United States · North America
TransPacific Venture Capital Partners is a venture capital firm that invests in healthcare companies across the Pacific Rim, spanning biopharmaceuticals, medical devices and digital healthcare services. It also invests in pre-IPO or emerging high-growth public companies listed on NASDAQ, the New York Stock Exchange and the Hong Kong Stock Exchange.
Invests inHealthcare & Biotech
In its own wordshealthcarebiopharmamedical devicesdigital healthartificial intelligencetherapeutics
Your fit with TransPacific Venture Capital Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsTransPacific Venture Capital Partners lists 10 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 75% of its companies are based in United States. It invests most often alongside Altamont Pharmaceutical Holdings, Boxer Capital and Decheng Capital.
No funding round on record names TransPacific Venture Capital Partners yet, so the figures come from its portfolio page.
Round figures show recent activity, not TransPacific Venture Capital Partners' whole history. Rounds on record name 0 companies; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 58th | 3 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers880%
- No longer answers00%
- Points to another company220%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Altamont Pharmaceutical Holdings
Compare TransPacific Venture Capital Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AnaptysBio manages financial collaborations with pharmaceutical companies | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| The company develops and tests immune-modulating therapies for cancer treatment. | Healthcare & Biotech | Portfolio page | ||
| Biomed Industries, Inc. develops innovative treatments for unmet needs in neurological diseases, metabolic diseases, and cardiovascular diseases with the help of AI and Machine Learning. | Healthcare & Biotech | Portfolio page | ||
| G1 Therapeutics develops and delivers next generation therapies to improve the lives and outcomes of people living with cancer. | Healthcare & Biotech | Portfolio page | ||
| Immuron Limited is a commercial and clinical stage biopharmaceutical company that develops and commercializes a novel class of specifically targeted polyclonal antibodies | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
Healthcare & Biotech | Portfolio page | |||
| Ovid Therapeutics is developing a next generation of targeted small molecule therapies to reduce seizures and deliver improved safety and tolerability for neurological diseases and brain conditions. | Healthcare & Biotech | Portfolio page | ||
| Zai Lab is a biopharmaceutical company that discovers, develops, and commercializes innovative products to address medical conditions with significant unmet needs | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- transpacificvc.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get TransPacific Venture Capital Partners' profile as data
Pull TransPacific Venture Capital Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/transpacificvc.com
# also
GET /v1/firms/transpacificvc.com/portfolio
GET /v1/firms/transpacificvc.com/coinvestors
GET /v1/firms/transpacificvc.com/news